Research

Risk of blood clots increases with the amount of time spent watching television, even if people get the recommended amount of physical activity, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017 in Anaheim, Calif. November 11 to 15, 2017.

Vermont is among the top ten states in per capita research funding in the U.S., according to a State of Research at the College presentation delivered by Larner College of Medicine Senior Associate Dean for Research Gordon Jensen, M.D., Ph.D., at the Dean’s Excellence in Research Awards event held November 13, 2017. The last of three 2017 Celebrating Excellence in Research events held at the College on November 10 and 13, 2017, the awards ceremony recognized the accomplishments of faculty, residents, medical students, graduate students and postdoctoral trainees.

New interdisciplinary research conducted by University of Vermont researcher Jane Nathan, Ph.D., and colleagues, has found that the Benson Henry Institute’s (BHI) evidence-based Stress Management and Resiliency Training (SMART) is a valuable model to use with health professionals to enhance their well-being.

On September 26, 2017 Vermont Business Magazine highlighted the appointment of Adam Atherly, Ph.D., as the first Director of Health Services Research at the University of Vermont Larner College of Medicine.

The Larner College of Medicine at the University of Vermont has announced the appointment of Adam Atherly, Ph.D., as the College’s first director of the health services research center and professor of medicine, effective February 1, 2018.

The FDA is right – when it comes to disease culprits, cigarette smoking tops the list. While recognized as the number-one cause of preventable disease and death, it’s an incredibly tough habit to break due to the addictiveness of nicotine. New research from the University of Vermont (UVM) and colleagues suggests that reducing nicotine content in cigarettes may decrease their addiction potential in especially vulnerable populations and suggests how regulatory policies could shift preferences to less-harmful tobacco products.

The Vermont Genetics Network (VGN) and Vermont Center for Immunology and Infectious Diseases (VCIID) at the University of Vermont hosted more than 300 National Institutes of Health-funded biomedical researchers from across Vermont, New Hampshire, Maine, Rhode Island and Delaware for the North East Regional IDeA Conference (NERIC) August 16 to 18, 2017 at the Sheraton Burlington Hotel. U.S. Senator Patrick Leahy delivered remarks at the conference on August 17.

University of Vermont researchers Sean Diehl, Ph.D., assistant professor of medicine and a Vaccine Testing Center immunologist, Sam Scarpino, Ph.D., former assistant professor of mathematics and statistics, Donna Rizzo, Ph.D., professor of engineering, and John Hanley, Ph.D., a postdoctoral associate in engineering, have been awarded the inaugural UVM Biomedical Engineering Program Pilot Research Program grant for their project, titled “Integrating omics and clinical data to study dengue infection.”

A five-year, $20 million National Institutes of Health (NIH) Clinical and Translational Research (CTR) Network grant will fund a joint program between the University of Vermont (UVM) and Maine Medical Center in Portland, Maine to develop and sustain a clinical and translational research infrastructure improving rural and community health for residents of Vermont, New Hampshire and Maine.

Two University of Vermont research teams have been awarded SPARK-VT grants by the university to help commercialize their work and move it a step closer to the marketplace, following a faculty pitch competition held June 16, 2017.